Astrazeneca Pharma India slips on Q2 profit drop
** Shares of Astrazeneca Pharma India ASTR.NS fall 5.1% to
6773.5 rupees
** Co posts 27% y/y drop in Q2 consolidated net profit to
384.3 mln rupees ($4.5 mln)
** ASTR set for worst session since Aug. 8, when it fell
6.6% on Q1 net loss
** However, stock on track to end week in the green,
snapping a 3-week losing run
** ASTR up 24% YTD
($1 = 84.4000 Indian rupees)
(Reporting by Bharath Rajeswaran in Bengaluru)
((bharath.rajeswaran@thomsonreuters.com; +91 9769003463;))
Recent news on Astrazeneca Pharma India
See all newsBrief: Astrazeneca Pharma India Receives Permission To Import And Sell Trastuzumab Deruxtecan For Additional Indication
Brief: Astrazeneca Pharma Says Bhavana Agrawal Resigns As CFO
Brief: Astrazeneca Pharma India Receives Permission To Import And Sell Benralizumab For Additional Indication
Brief: Astrazeneca Pharma India Receives Permission To Import Benralizumab (Fasenra) For Additional Indication
Brief: Astrazeneca Pharma Gets Permission To Import For Sale Of Trastuzumab Deruxtecan